Recall Record

Dallas, TX, United States

Brian P. Richardson recalls

1 recall recorded since 2018, most recently on 5 April 2019. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)1

Terminated Class I Drugs

Recall started
5 April 2019
Terminated
19 January 2022
Reason
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to be tainted with undeclared sildenafil and tadalafil, two FDA approved drugs for the treatment of male erectile dysfunction, making this an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-1206-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.